Watchlist Manager

Watchlist

Price: 148.07 CNY -0.61% Market Closed

Market Cap: ¥89.3B

	Zhangzhou Pientzehuang Pharmaceutical Co Ltd SSE:600436	CN

Income Statement

Currency: CNY

	Dec-2003	Mar-2004	Jun-2004	Sep-2004	Dec-2004	Mar-2005	Jun-2005	Sep-2005	Dec-2005	Mar-2006	Jun-2006	Sep-2006	Dec-2006	Mar-2007	Jun-2007	Sep-2007	Dec-2007	Mar-2008	Jun-2008	Sep-2008	Dec-2008	Mar-2009	Jun-2009	Sep-2009	Dec-2009	Mar-2010	Jun-2010	Sep-2010	Dec-2010	Mar-2011	Jun-2011	Sep-2011	Dec-2011	Mar-2012	Jun-2012	Sep-2012	Dec-2012	Mar-2013	Jun-2013	Sep-2013	Dec-2013	Mar-2014	Jun-2014	Sep-2014	Dec-2014	Mar-2015	Jun-2015	Sep-2015	Dec-2015	Mar-2016	Jun-2016	Sep-2016	Dec-2016	Mar-2017	Jun-2017	Sep-2017	Dec-2017	Mar-2018	Jun-2018	Sep-2018	Dec-2018	Mar-2019	Jun-2019	Sep-2019	Dec-2019	Mar-2020	Jun-2020	Sep-2020	Dec-2020	Mar-2021	Jun-2021	Sep-2021	Dec-2021	Mar-2022	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Jun-2023	Sep-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024	Mar-2025	Jun-2025	Sep-2025
Revenue
Interest Expense	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	9	0	0	0	8	0	0	0	7	0	0	0	20	0	0	0	22	0	0	0	20	0	0	0	18	0	0	0	27	0	0	5	24	17	23	26	28	30	31	32	31	31	31	28	27	27	26	30	33	33	34	37	38	41	41	39	38	37	39	38	40	37	0	0
Revenue	214 N/A	196 -8%	230 +17%	248 +7%	254 +2%	224 -12%	252 +12%	324 +29%	419 +29%	490 +17%	526 +7%	535 +2%	531 -1%	559 +5%	569 +2%	584 +3%	593 +1%	618 +4%	622 +1%	629 +1%	650 +3%	630 -3%	652 +3%	684 +5%	695 +2%	735 +6%	768 +4%	806 +5%	867 +8%	938 +8%	941 +0%	968 +3%	1 022 +6%	1 022 +0%	1 107 +8%	1 171 +6%	1 171 0%	1 245 +6%	1 313 +5%	1 348 +3%	1 396 +4%	1 436 +3%	1 446 +1%	1 409 -3%	1 454 +3%	1 455 +0%	1 503 +3%	1 698 +13%	1 886 +11%	1 975 +5%	2 032 +3%	2 180 +7%	2 309 +6%	2 701 +17%	3 101 +15%	3 428 +11%	3 714 +8%	4 076 +10%	4 365 +7%	4 555 +4%	4 766 +5%	5 028 +5%	5 257 +5%	5 522 +5%	5 722 +4%	5 953 +4%	6 074 +2%	6 451 +6%	6 511 +1%	6 798 +4%	7 113 +5%	7 553 +6%	8 022 +6%	8 368 +4%	8 595 +3%	8 526 -1%	8 694 +2%	8 975 +3%	9 317 +4%	9 678 +4%	10 058 +4%	10 600 +5%	10 664 +1%	10 909 +2%	10 788 -1%	10 759 0%	10 516 -2%	9 780 -7%
Gross Profit
Cost of Revenue	(72)	(68)	(80)	(84)	(87)	0	(105)	(158)	(220)	(286)	(320)	(338)	(342)	(352)	(363)	(377)	(379)	(398)	(405)	(401)	(412)	(401)	(402)	(427)	(436)	(464)	(476)	(495)	(541)	(559)	(554)	(547)	(567)	(533)	(571)	(595)	(559)	(605)	(636)	(631)	(643)	(676)	(706)	(715)	(735)	(732)	(743)	(867)	(1 008)	(1 057)	(1 030)	(1 088)	(1 195)	(1 494)	(1 805)	(2 043)	(2 115)	(2 330)	(2 504)	(2 605)	(2 754)	(2 934)	(3 053)	(3 174)	(3 198)	(3 328)	(3 384)	(3 517)	(3 584)	(3 771)	(3 819)	(3 840)	(3 968)	(4 189)	(4 412)	(4 614)	(4 735)	(4 964)	(5 164)	(5 264)	(5 363)	(5 748)	(5 876)	(6 118)	(6 189)	(6 300)	(6 328)	(6 164)
Gross Profit	141 N/A	129 -9%	150 +17%	163 +9%	167 +2%	0 N/A	146 N/A	165 +13%	199 +20%	204 +3%	206 +1%	197 -5%	189 -4%	206 +9%	207 +0%	207 +0%	214 +3%	220 +3%	218 -1%	228 +5%	238 +4%	229 -4%	250 +9%	257 +3%	259 +1%	271 +5%	292 +8%	310 +6%	326 +5%	379 +16%	387 +2%	421 +9%	454 +8%	489 +8%	536 +10%	577 +8%	612 +6%	641 +5%	677 +6%	717 +6%	753 +5%	760 +1%	740 -3%	694 -6%	719 +4%	723 +1%	760 +5%	831 +9%	878 +6%	919 +5%	1 003 +9%	1 091 +9%	1 114 +2%	1 207 +8%	1 297 +7%	1 385 +7%	1 599 +15%	1 746 +9%	1 861 +7%	1 950 +5%	2 012 +3%	2 094 +4%	2 204 +5%	2 348 +7%	2 524 +8%	2 624 +4%	2 690 +3%	2 933 +9%	2 927 0%	3 027 +3%	3 294 +9%	3 712 +13%	4 054 +9%	4 179 +3%	4 184 +0%	3 911 -7%	3 959 +1%	4 012 +1%	4 153 +4%	4 414 +6%	4 695 +6%	4 851 +3%	4 788 -1%	4 791 +0%	4 599 -4%	4 459 -3%	4 188 -6%	3 616 -14%
Operating Income
Operating Expenses	(59)	(56)	(63)	(66)	(93)	0	(87)	(95)	(77)	(80)	(77)	(75)	(73)	(77)	(78)	(80)	(85)	(89)	(99)	(100)	(114)	(111)	(108)	(113)	(106)	(111)	(105)	(102)	(95)	(109)	(127)	(134)	(154)	(159)	(174)	(188)	(213)	(216)	(212)	(221)	(262)	(276)	(281)	(295)	(284)	(276)	(292)	(313)	(368)	(380)	(419)	(448)	(523)	(534)	(573)	(610)	(712)	(727)	(756)	(748)	(768)	(795)	(829)	(908)	(954)	(1 002)	(1 023)	(1 140)	(1 116)	(1 079)	(1 154)	(1 055)	(1 320)	(1 302)	(1 217)	(1 138)	(1 136)	(1 079)	(1 044)	(1 159)	(1 448)	(1 362)	(1 346)	(1 256)	(1 176)	(1 023)	(1 114)	(1 137)
Selling, General & Administrative	(60)	(57)	(63)	(67)	(94)	0	(88)	(96)	(78)	(80)	(75)	(73)	(71)	(75)	(78)	(80)	(84)	(88)	(97)	(98)	(111)	(108)	(108)	(113)	(106)	(112)	(122)	(128)	(124)	(139)	(141)	(139)	(148)	(160)	(174)	(191)	(181)	(208)	(203)	(207)	(206)	(259)	(266)	(281)	(227)	(275)	(288)	(306)	(303)	(368)	(398)	(431)	(428)	(524)	(571)	(589)	(603)	(675)	(707)	(708)	(628)	(665)	(662)	(716)	(800)	(865)	(900)	(1 016)	(960)	(1 003)	(1 062)	(956)	(1 003)	(1 040)	(962)	(894)	(844)	(830)	(796)	(890)	(1 156)	(1 158)	(1 146)	(1 087)	(860)	(789)	(855)	(852)
Research & Development	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(23)	0	0	0	(47)	0	0	0	(45)	0	0	0	(50)	0	0	0	(67)	0	0	(20)	(70)	0	0	(46)	(96)	(92)	(125)	(141)	(116)	(132)	(122)	(126)	(93)	(89)	(104)	(103)	(194)	(256)	(249)	(245)	(225)	(245)	(236)	(267)	(207)	(228)	(232)	(197)	(258)	(252)	(274)	(305)
Depreciation & Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(9)	0	0	0	(8)	0	0	0	(11)	0	0	0	(14)	0	0	0	(26)	0	0	0	(47)	0	0	0	(49)	0	0	0	(48)	0	0	0	(83)	0	0	0	(126)	0	0	0	(74)	0	0	0	(104)	0	0	0	(82)	0	0	0
Other Operating Expenses	1	1	0	1	1	0	1	1	1	1	(2)	(2)	(2)	(2)	(0)	(0)	(1)	0	(2)	(2)	(3)	(3)	(0)	0	(1)	0	17	26	29	30	14	5	(6)	1	0	3	(1)	(8)	(9)	(14)	(1)	(17)	(15)	(13)	(1)	(2)	(4)	(7)	(1)	(12)	(20)	(18)	(2)	(10)	(2)	(1)	9	(52)	(49)	6	5	(39)	(43)	(51)	10	(6)	(1)	2	20	12	12	5	2	(6)	(6)	1	7	(4)	(11)	(2)	19	24	32	28	24	17	15	20
Operating Income	83 N/A	73 -12%	87 +20%	97 +11%	74 -24%	65 -12%	59 -9%	70 +20%	121 +72%	125 +3%	129 +3%	121 -6%	116 -4%	130 +12%	129 -1%	127 -2%	129 +2%	131 +2%	118 -10%	128 +8%	124 -3%	117 -5%	142 +21%	144 +1%	152 +6%	161 +5%	187 +17%	208 +11%	231 +11%	270 +17%	260 -4%	287 +10%	301 +5%	331 +10%	363 +10%	389 +7%	399 +3%	425 +6%	465 +10%	497 +7%	491 -1%	484 -1%	459 -5%	399 -13%	436 +9%	447 +3%	468 +5%	519 +11%	510 -2%	539 +6%	584 +8%	643 +10%	591 -8%	673 +14%	723 +8%	775 +7%	888 +15%	1 019 +15%	1 105 +9%	1 202 +9%	1 243 +3%	1 299 +4%	1 375 +6%	1 440 +5%	1 570 +9%	1 622 +3%	1 667 +3%	1 794 +8%	1 811 +1%	1 949 +8%	2 140 +10%	2 657 +24%	2 733 +3%	2 877 +5%	2 967 +3%	2 773 -7%	2 823 +2%	2 932 +4%	3 109 +6%	3 255 +5%	3 247 0%	3 489 +7%	3 442 -1%	3 534 +3%	3 423 -3%	3 435 +0%	3 074 -11%	2 479 -19%
Pre-Tax Income
Interest Income Expense	7	12	14	10	3	0	(1)	4	11	5	4	13	9	10	16	9	18	13	32	30	44	42	21	20	0	1	(2)	(3)	(0)	(1)	3	4	5	5	3	(2)	(9)	(13)	(15)	4	11	17	23	18	73	70	87	85	32	40	23	19	20	19	34	47	41	44	37	36	108	112	119	115	69	85	105	112	126	111	105	125	113	118	124	114	142	140	128	133	146	134	150	145	145	149	139	391
Non-Reccuring Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(5)	0	0	0	(0)	0	0	0	0	0	0	0	(6)	(4)	(4)	(4)	19	6	22	22	(31)	10	(5)	(5)	(1)	5	5	5	41	42	42	43	27	28	36	38	10	11	4	1	1	2	4	5	5	3	6	5
Gain/Loss on Disposition of Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(1)	0	0	0	(0)	0	0	0	(0)	0	0	0	(1)	0	0	0	(1)	0	0	0	(0)	0	0	0	(1)	0	0	(2)	(0)	0	(3)	(3)	(3)	(3)	(1)	(1)	(0)	0	(0)	0	(1)	0	(1)	0	(0)	0	0	0	(0)	0	0	0	(0)	0	0	0	0	0	0	0	0	0	0	0	(1)	0	0	0	(1)	0	0	0
Total Other Income	1	1	2	(0)	1	0	1	1	1	8	6	1	0	0	(1)	0	2	1	1	1	1	1	1	1	1	1	0	1	2	1	0	(0)	0	(0)	(0)	25	26	26	31	6	14	15	14	15	10	9	10	11	11	11	8	5	5	3	1	1	(5)	(3)	(9)	(8)	8	7	14	18	7	12	11	7	2	(5)	(5)	(7)	(4)	(4)	(4)	(2)	3	2	1	0	(24)	(26)	(25)	(25)	(33)	(36)	(38)	(39)
Pre-Tax Income	91 N/A	86 -5%	103 +19%	106 +3%	78 -26%	0 N/A	59 N/A	75 +27%	134 +79%	138 +3%	138 +0%	137 -1%	126 -8%	140 +11%	144 +3%	136 -6%	148 +9%	144 -3%	152 +5%	160 +5%	168 +5%	160 -5%	164 +2%	165 +1%	153 -7%	162 +6%	186 +15%	206 +11%	232 +13%	270 +16%	263 -2%	290 +10%	305 +5%	335 +10%	365 +9%	412 +13%	415 +1%	437 +5%	481 +10%	507 +5%	510 +0%	515 +1%	495 -4%	430 -13%	518 +20%	526 +2%	563 +7%	612 +9%	550 -10%	587 +7%	614 +5%	666 +8%	609 -9%	690 +13%	755 +9%	819 +9%	942 +15%	1 065 +13%	1 154 +8%	1 250 +8%	1 328 +6%	1 428 +8%	1 503 +5%	1 568 +4%	1 645 +5%	1 724 +5%	1 788 +4%	1 917 +7%	1 979 +3%	2 097 +6%	2 284 +9%	2 818 +23%	2 869 +2%	3 019 +5%	3 122 +3%	2 923 -6%	2 978 +2%	3 086 +4%	3 241 +5%	3 388 +5%	3 369 -1%	3 599 +7%	3 570 -1%	3 659 +3%	3 539 -3%	3 551 +0%	3 182 -10%	2 836 -11%
Net Income
Tax Provision	(30)	(28)	(33)	(36)	(36)	(32)	(34)	(36)	(46)	(48)	(47)	(45)	(44)	(50)	(49)	(48)	(52)	(46)	(40)	(45)	(27)	(22)	(25)	(17)	(23)	(24)	(26)	(30)	(38)	(43)	(45)	(48)	(48)	(55)	(56)	(68)	(65)	(69)	(76)	(81)	(78)	(76)	(72)	(58)	(80)	(86)	(89)	(100)	(86)	(93)	(94)	(96)	(102)	(111)	(134)	(145)	(161)	(179)	(189)	(207)	(199)	(213)	(224)	(229)	(258)	(270)	(274)	(299)	(290)	(295)	(336)	(421)	(404)	(441)	(455)	(427)	(455)	(471)	(477)	(494)	(518)	(546)	(557)	(555)	(543)	(541)	(487)	(425)
Income from Continuing Operations	61	59	70	70	42	30	25	39	87	90	91	91	82	90	95	88	96	98	112	115	142	138	138	148	130	137	159	176	195	227	218	243	257	280	309	344	351	368	405	427	431	439	422	373	438	439	474	512	463	495	520	571	507	579	621	675	780	887	965	1 044	1 129	1 215	1 279	1 339	1 387	1 453	1 514	1 619	1 689	1 802	1 948	2 397	2 465	2 578	2 667	2 496	2 523	2 615	2 765	2 894	2 851	3 053	3 013	3 105	2 996	3 010	2 695	2 411
Income to Minority Interest	(0)	(0)	(0)	(0)	(0)	0	(0)	(0)	(1)	(1)	(1)	(2)	(2)	(2)	(2)	(1)	(1)	(1)	(1)	(1)	(1)	(1)	(1)	(1)	(1)	(0)	(0)	0	(1)	(1)	(0)	(1)	(2)	(1)	(2)	(2)	(2)	(2)	(2)	(4)	(1)	(1)	(0)	1	1	1	(0)	1	3	3	(0)	4	29	37	43	55	27	20	27	9	14	6	(7)	(7)	(13)	(16)	(21)	(24)	(18)	(33)	(26)	(43)	(33)	(23)	(37)	(24)	(51)	(62)	(66)	(70)	(54)	(51)	(34)	(25)	(19)	(8)	3	9
Net Income (Common)	61 N/A	58 -3%	70 +20%	70 0%	42 -40%	30 -27%	24 -20%	38 +56%	86 +127%	89 +3%	90 +1%	89 0%	80 -10%	88 +10%	93 +6%	86 -7%	95 +10%	97 +1%	111 +15%	114 +3%	141 +24%	137 -3%	137 N/A	147 +7%	130 -12%	137 +6%	159 +16%	176 +10%	194 +10%	226 +16%	218 -4%	242 +11%	255 +5%	279 +9%	307 +10%	342 +11%	349 +2%	366 +5%	403 +10%	423 +5%	430 +2%	438 +2%	422 -4%	373 -12%	439 +18%	440 +0%	474 +8%	513 +8%	467 -9%	497 +7%	520 +5%	575 +11%	536 -7%	616 +15%	664 +8%	730 +10%	807 +11%	907 +12%	991 +9%	1 052 +6%	1 143 +9%	1 221 +7%	1 272 +4%	1 332 +5%	1 374 +3%	1 438 +5%	1 493 +4%	1 594 +7%	1 672 +5%	1 769 +6%	1 922 +9%	2 354 +22%	2 432 +3%	2 555 +5%	2 631 +3%	2 472 -6%	2 472 0%	2 553 +3%	2 699 +6%	2 825 +5%	2 797 -1%	3 002 +7%	2 978 -1%	3 079 +3%	2 977 -3%	3 002 +1%	2 698 -10%	2 420 -10%
EPS (Diluted)	0.1 N/A	0.1 N/A	0.12 +20%	0.11 -8%	0.07 -36%	0 N/A	0.03 N/A	0.06 +100%	0.15 +150%	0.16 +7%	0.17 +6%	0.17 N/A	0.14 -18%	0.16 +14%	0.16 N/A	0.15 -6%	0.16 +7%	0.17 +6%	0.2 +18%	0.2 N/A	0.24 +20%	0.23 -4%	0.23 N/A	0.25 +9%	0.22 -12%	0.24 +9%	0.28 +17%	0.31 +11%	0.33 +6%	0.39 +18%	0.37 -5%	0.41 +11%	0.44 +7%	0.49 +11%	0.54 +10%	0.6 +11%	0.6 N/A	0.63 +5%	0.69 +10%	0.72 +4%	0.73 +1%	0.73 N/A	0.7 -4%	0.61 -13%	0.81 +33%	0.8 -1%	0.78 -3%	0.85 +9%	0.77 -9%	0.83 +8%	0.86 +4%	0.95 +10%	0.89 -6%	1.02 +15%	1.1 +8%	1.21 +10%	1.34 +11%	1.5 +12%	1.64 +9%	1.74 +6%	1.89 +9%	2.02 +7%	2.11 +4%	2.21 +5%	2.28 +3%	2.39 +5%	2.48 +4%	2.65 +7%	2.77 +5%	2.94 +6%	3.19 +9%	3.91 +23%	4.03 +3%	4.24 +5%	4.36 +3%	4.1 -6%	4.1 N/A	4.23 +3%	4.47 +6%	4.68 +5%	4.64 -1%	4.98 +7%	4.94 -1%	5.1 +3%	4.93 -3%	4.98 +1%	4.47 -10%	4.01 -10%

Income Statement Balance Sheet Cash Flow Statement

Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436

Income Statement

Earnings Waterfall
Zhangzhou Pientzehuang Pharmaceutical Co Ltd

Income Statement
Zhangzhou Pientzehuang Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

Zhangzhou Pientzehuang Pharmaceutical Co Ltd SSE:600436

Income Statement

Earnings Waterfall Zhangzhou Pientzehuang Pharmaceutical Co Ltd

Income Statement Zhangzhou Pientzehuang Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436

Earnings Waterfall
Zhangzhou Pientzehuang Pharmaceutical Co Ltd

Income Statement
Zhangzhou Pientzehuang Pharmaceutical Co Ltd